BIOCRYST PHARMACEUTICA

NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

07 авг 2024 09:45:08 Источник NetDania Notify

BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update

05 авг 2024 07:00:24 Источник Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 авг 2024 07:00:47 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

29 июл 2024 09:56:40 Источник NetDania Notify

BioCryst to Report Second Quarter 2024 Financial Results on August 5

22 июл 2024 07:00:09 Источник Nasdaq GlobeNewswire

ORLADEYO® (berotralstat) Approved in Peru

09 июл 2024 07:00:00 Источник Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 июл 2024 07:00:06 Источник Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 июн 2024 07:00:59 Источник Nasdaq GlobeNewswire

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment

02 июн 2024 04:00:13 Источник Nasdaq GlobeNewswire

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology

14 май 2024 07:00:53 Источник Nasdaq GlobeNewswire

ORLADEYO® (berotralstat) Approved in Mexico

13 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)

09 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

BioCryst to Present at Upcoming Investor Conferences

07 май 2024 07:00:22 Источник Nasdaq GlobeNewswire

BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update

06 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 май 2024 07:00:07 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

25 апр 2024 09:45:08 Источник NetDania Notify

NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

24 апр 2024 09:54:30 Источник NetDania Notify

BioCryst to Report First Quarter 2024 Financial Results on May 6

22 апр 2024 07:00:50 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK

19 апр 2024 11:04:56 Источник NetDania Notify

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency

17 апр 2024 04:30:39 Источник Nasdaq GlobeNewswire